| Name | Title | Contact Details |
|---|
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.
Grady Memorial Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Grady Memorial Hospital is based in Chickasha, OK. You can find more information on Grady Memorial Hospital at www.gradymem.org
Bay Area Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Bay Area Hospital is based in Coos Bay, OR. You can find more information on Bay Area Hospital at www.bayareahospital.org
Onvoi is a Roseville, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Clarendon Memorial Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Manning, SC. To find more information about Clarendon Memorial Hospital, please visit www.clarendonhealth.com